Search

everythinglearnresearchcommunity

for

Search:↓

Combination therapy with fesoterodine and doxazosin improves bladder function and delays BPH progression.

Finasteride and dutasteride's effects are mainly due to target binding saturation and slow enzyme turnover.

High doses of progesterone can reduce seizures in mice.

Topical prostaglandin analogues may improve hair density in androgenetic alopecia, but more research is needed.

Viprostol does not effectively promote hair growth in male pattern baldness.

Flutamide and a new synthetic steroid affected brain and prostate chemicals and showed potential for treating androgen-related conditions and epilepsy.

Clascoterone may be an effective topical treatment for hair loss.

Bimatoprost shows promise for treating vitiligo, especially when combined with other therapies.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair cells.

The new compounds may be more effective and cheaper than current treatments for conditions like baldness.

Progesterone protects neurons from damage by converting to allopregnanolone, which works through GABAA receptors.

Finasteride may affect PNMT, causing side effects.

Neuroactive steroids affect cocaine's rewarding effects through the sigma1 receptor.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

Dutasteride is more effective than finasteride for treating BPH without extra safety risks.

Combination therapy improves urinary flow and reduces residual urine, but needs better stent design.

A peptide known for reducing wrinkles also effectively inhibits an enzyme linked to skin inflammation and acne.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

Pregnenolone might help manage movement issues caused by Parkinson's disease treatment without reducing the medicine's effectiveness.

Progesterone can reduce seizures without relying on the GABAA receptor pathway.

Sonidegib and vismodegib have different side effects and reporting patterns.

5α-reductase affects dopamine receptors linked to sensorimotor gating, which may help understand disorders like schizophrenia.

Prostaglandin helps regenerate hair follicles after radiation damage.

Dutasteride effectively treats benign prostatic hyperplasia, improving symptoms and quality of life.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Neuroactive steroids show promise for treating mental and neurological disorders by targeting GABA_A receptors.

The inhibitor DPP can promote hair growth.

The document concludes that biotin, folate, and RGD peptides are promising for targeting cancer cells with prodrugs, but the conjugates are not yet tested for use.